INDIAGLYCO

India Glycols Share Price

₹1,331.10 -45.6 (-3.31%)

21 Dec, 2024 19:13

SIP TrendupStart SIP in INDIAGLYCO

Start SIP

Performance

  • Low
  • ₹1,325
  • High
  • ₹1,411
  • 52 Week Low
  • ₹679
  • 52 Week High
  • ₹1,549
  • Open Price₹1,377
  • Previous Close₹1,377
  • Volume82,380

Investment Returns

  • Over 1 Month + 16.46%
  • Over 3 Month + 5.95%
  • Over 6 Month + 45.22%
  • Over 1 Year + 82.62%
SIP Lightning

Smart Investing Starts Here Start SIP with India Glycols for Steady Growth!

Invest Now

India Glycols Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 21.3
  • PEG Ratio
  • 1
  • Market Cap Cr
  • 4,121
  • P/B Ratio
  • 2
  • Average True Range
  • 57.35
  • EPS
  • 62.64
  • Dividend Yield
  • 0.6
  • MACD Signal
  • 41.18
  • RSI
  • 49.44
  • MFI
  • 72.2

India Glycols Financials

India Glycols Technicals

EMA & SMA

Current Price
₹1,331.10
-45.6 (-3.31%)
pointer
  • stock-down_img
  • Bullish Moving Average 8
  • stock-up_img
  • Bearish Moving Average 8
  • 20 Day
  • ₹1,351.04
  • 50 Day
  • ₹1,304.35
  • 100 Day
  • ₹1,241.63
  • 200 Day
  • ₹1,123.03

Resistance and Support

1355.73 Pivot Speed
  • R3 1,472.27
  • R2 1,441.63
  • R1 1,386.37
  • S1 1,300.47
  • S2 1,269.83
  • S3 1,214.57

What's your outlook on India Glycols?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

India Glycols Ltd. is a leading manufacturer of specialty chemicals and ethylene glycol in India. The company produces a wide range of products, including antifreeze, solvents, and surfactants, serving diverse industries such as automotive, textiles, and personal care.

India Glycols (Nse) has an operating revenue of Rs. 3,760.20 Cr. on a trailing 12-month basis. An annual revenue growth of 24% is outstanding, Pre-tax margin of 6% is okay, ROE of 8% is fair but needs improvement. The company has a reasonable debt to equity of 35%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 5% and 28% from 50DMA and 200DMA. It is currently FORMING a base in its weekly chart and is trading around 11% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 60 which is a FAIR score but needs to improve its earnings, a RS Rating of 80 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 94 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

India Glycols Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-07 Quarterly Results
2024-07-29 Quarterly Results
2024-05-28 Audited Results & Final Dividend
2024-02-02 Quarterly Results
2023-11-03 Quarterly Results

India Glycols F&O

India Glycols Shareholding Pattern

61.01%
1.93%
2.9%
0%
26.78%
7.38%

About India Glycols

  • NSE Symbol
  • INDIAGLYCO
  • BSE Symbol
  • 500201
  • Chairman & Managing Director
  • Mr. U S Bhartia
  • ISIN
  • INE560A01015

Similar Stocks to India Glycols

India Glycols FAQs

India Glycols share price is ₹1,331 As on 21 December, 2024 | 18:59

The Market Cap of India Glycols is ₹4121.3 Cr As on 21 December, 2024 | 18:59

The P/E ratio of India Glycols is 21.3 As on 21 December, 2024 | 18:59

The PB ratio of India Glycols is 2 As on 21 December, 2024 | 18:59

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23